Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AOWDF OTCMKTS:BRRZY OTCMKTS:IQEPF OTCMKTS:OPHRY OTCMKTS:OXBDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAOWDFAO World$2.05$2.05$1.99▼$3.27$938.42M-0.17900 shsN/ABRRZYTotal Brain$5.00$5.00$5.00▼$5.00$53.13M5.180 shsN/AIQEPFIQE$0.13-4.7%$0.14$0.10▼$0.44$127.33M1.5270 shs1,000 shsOPHRYOPHIR ENERGY PL/ADR$1.48+5.7%$1.48$0.50▼$1.79$523.27M0.5116,436 shs2,000 shsOXBDFOxford BioMedica$4.77+2.6%$4.27$3.15▼$5.68$505.44M1.11600 shs7,507 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAOWDFAO World0.00%0.00%0.00%0.00%0.00%BRRZYTotal Brain0.00%0.00%0.00%0.00%0.00%IQEPFIQE0.00%-4.62%-8.64%+27.90%-68.48%OPHRYOPHIR ENERGY PL/ADR0.00%0.00%0.00%0.00%0.00%OXBDFOxford BioMedica+2.58%+12.77%+2.36%+51.43%+28.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAOWDFAO WorldN/AN/AN/AN/AN/AN/AN/AN/ABRRZYTotal BrainN/AN/AN/AN/AN/AN/AN/AN/AIQEPFIQEN/AN/AN/AN/AN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AN/AN/AN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAOWDFAO World 0.00N/AN/AN/ABRRZYTotal Brain 0.00N/AN/AN/AIQEPFIQE 0.00N/AN/AN/AOPHRYOPHIR ENERGY PL/ADR 0.00N/AN/AN/AOXBDFOxford BioMedica 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAOWDFAO World$2.13B0.44N/AN/A$0.22 per share9.30BRRZYTotal Brain$2.60M20.43N/AN/A$1.67 per share2.99IQEPFIQE$150.84M0.84$0.00 per share33.10$0.18 per share0.73OPHRYOPHIR ENERGY PL/ADR$188.53M2.78N/AN/A$4.14 per share0.36OXBDFOxford BioMedica$111.34M4.54N/AN/A$1.01 per share4.72Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAOWDFAO World-$41.52MN/A0.00204.54N/AN/AN/AN/AN/ABRRZYTotal Brain-$5.14MN/A0.00∞N/AN/AN/AN/AN/AIQEPFIQE-$48.79MN/A0.00∞N/AN/AN/AN/A9/8/2025 (Estimated)OPHRYOPHIR ENERGY PL/ADR-$111.79MN/A0.0013.45N/AN/AN/AN/AN/AOXBDFOxford BioMedica-$195.90MN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAOWDFAO WorldN/AN/AN/AN/AN/ABRRZYTotal BrainN/AN/AN/AN/AN/AIQEPFIQEN/AN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAOWDFAO WorldN/A0.760.50BRRZYTotal BrainN/AN/AN/AIQEPFIQE0.191.511.02OPHRYOPHIR ENERGY PL/ADRN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAOWDFAO WorldN/ABRRZYTotal BrainN/AIQEPFIQEN/AOPHRYOPHIR ENERGY PL/ADRN/AOXBDFOxford BioMedicaN/AInsider OwnershipCompanyInsider OwnershipAOWDFAO WorldN/ABRRZYTotal BrainN/AIQEPFIQEN/AOPHRYOPHIR ENERGY PL/ADRN/AOXBDFOxford BioMedicaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAOWDFAO World4,442458.79 millionN/ANot OptionableBRRZYTotal BrainN/A10.63 millionN/ANot OptionableIQEPFIQE685971.28 millionN/ANot OptionableOPHRYOPHIR ENERGY PL/ADR386353.56 millionN/ANot OptionableOXBDFOxford BioMedica891105.96 millionN/ANot OptionableOXBDF, BRRZY, OPHRY, AOWDF, and IQEPF HeadlinesRecent News About These CompaniesOxford BioMedica completes purchase of last 10% stake in US subsidiaryJune 23, 2025 | lse.co.ukOxford BioMedica (OTCMKTS:OXBDF) Trading Down 8.2% - What's Next?June 19, 2025 | marketbeat.comOxford BioMedica touts strong first-half momentum ahead of meetingJune 11, 2025 | lse.co.ukOxford Biomedica Full Year 2024 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comOxford BioMedica (OXBDF) Receives a Buy from RBC CapitalApril 15, 2025 | theglobeandmail.comWhen Will Oxford Biomedica plc (LON:OXB) Turn A Profit?April 10, 2025 | uk.finance.yahoo.comOxford Biomedica sees FY25 revenue GBP 160M-GBP 170MApril 9, 2025 | msn.comOxford Biomedica prepares statements on ‘going concern basis’April 9, 2025 | msn.comOxford Biomedica plc (OXBDF) Q4 2024 Earnings Call TranscriptApril 9, 2025 | seekingalpha.comOxford Biomedica annual loss narrows; hails "commercial momentum"April 9, 2025 | lse.co.ukOxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trialFebruary 20, 2025 | markets.businessinsider.comOxford Biomedica appoints joint corporate broker, joint financial advisorFebruary 5, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting Rights for 2024January 2, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting RightsDecember 2, 2024 | markets.businessinsider.comOxford Biomedica Aligns Executive Incentives with GoalsNovember 23, 2024 | markets.businessinsider.comSanofi hands back gene therapies to Oxford BiomedicaNovember 15, 2024 | pharmaphorum.comPOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comOxford Biomedica posts strong revenue growth in first half resultsSeptember 23, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOXBDF, BRRZY, OPHRY, AOWDF, and IQEPF Company DescriptionsAO World OTCMKTS:AOWDF$2.05 0.00 (0.00%) As of 12/15/2022AO World plc, together with its subsidiaries, engages in the online retailing of domestic appliances the United Kingdom and Germany. It retails fridge freezers, cookers and washing machines, and audiovisual equipment, as well as computing, mobile, gaming, and smart home technology products. The company also provides logistics and transport services. In addition, it engages in the investment activities; and waste electrical and electronic equipment (WEEE) recycling activities. The company sells its products through its websites, marketplaces, and third-party websites. AO World plc was founded in 2000 and is headquartered in Bolton, the United Kingdom.Total Brain OTCMKTS:BRRZY$5.00 0.00 (0.00%) As of 07/23/2021Total Brain Limited, together with its subsidiaries, develops and sells brain health products in the United States. It offers Total Brain, a neuroscience-based mental health and brain performance app. Total Brain Limited has a partnership with the Center for Adolescent Research and Education to address growing youth mental health crisis. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was founded in 2000 and is based in Surry Hills, Australia.IQE OTCMKTS:IQEPF$0.13 -0.01 (-4.65%) As of 07/8/2025 09:30 AM EasternIQE plc, together with its subsidiaries, develops, manufactures, and sells advanced semiconductor materials. It operates through three segments: Wireless, Photonics, and CMOS++. The company manufactures and sells compound semiconductor materials for the wireless market which includes radio frequency devices for wireless communications, and photonics market, that includes applications that transmit and sense visible and infrared lights, as well as advanced semiconductor materials related to silicon. It operates in the United States, rest of the Americas, France, Germany, Israel, the United Kingdom, rest of Europe, the Middle East, Africa, the People's Republic of China, Japan, Taiwan, and rest of the Asia-Pacific. The company was founded in 1988 and is headquartered in Cardiff, the United Kingdom.OPHIR ENERGY PL/ADR OTCMKTS:OPHRY$1.48 +0.08 (+5.71%) As of 05/9/2019Ophir Energy plc engages in the exploration, development, and production of upstream oil and gas properties in Asia and Africa. The company develops offshore and deep-water oil and gas exploration assets. It has 1 billion barrel of oil equivalent of reserves and resources. Ophir Energy plc was founded in 2004 and is headquartered in London, the United Kingdom.Oxford BioMedica OTCMKTS:OXBDF$4.77 +0.12 (+2.58%) As of 07/9/2025 03:55 PM EasternOxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group: Up 385%, Analysts Say It’s Still a Bargain BigBear.ai: Why a 90% Rally Could Be Just the Start Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Alphabet: Technical Momentum Is Starting to Turn Boeing's Rebound Is Well Underway—But Is It Too Late? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
